Antibiotic use and resistance - Proving the obvious

Lancet

Volumn 365, Issue 9459, 2005, Pages 548-549

  Turnidge, John ^a   Christiansen, Keryn ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG USE; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 13844253698     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70770-4     Document Type: Note

References (13)

1. European Surveillance of Antimicrobial Consumption. 2003: http://www.ua.ac.be/esac (accessed Dec 30, 2004).
2. Sommet A, Sermet C, Boelle PY, Tafflet M, Bernede C, Guillemot D. No significant decrease in antibiotic use from 1992 to 2000, in the French community. J Antimicrob Chemother. 54:2004;524-528
3. Bruinsma N, Hutchinson JM, van den Bogaard AE., Giamarellou H, Degener J, Stobberingh EE. Influence of population density on antibiotic resistance. J Antimicrob Chemother. 51:2003;385-390
4. Holmes SJ, Morrow AL, Pickering LK. Child-care practices: effects of social change on the epidemiology of infectious diseases and antibiotic resistance. Epidemiol Rev. 18:1996;10-28
5. Whitney CG, Klugman KP. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin Pediatr Infect Dis. 15:2004;86-93
6. Munch-Petersen E, Boundy C. Yearly incidence of penicillin-resistant staphylococci in man since 1942. Bull World Health Organ. 26:1962;241-252
7. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA. 96:1999;1152-1156
8. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance amongst Streptococcus pyogenes isolates in Spain. J Clin Microbiol. 40:2002;2959-2963
9. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R. Importance of local variations in antibiotic consumption and geographic differences or erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol. 40:2002;159-164
10. Bergman M, Huikko S, Pihlajamäki M, for the Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38: 1251-56.
11. Monnet DL, Archibald LK, Phillips L, for the Intensive Care Antimicrobial Resistance Epidemiology Project and the National Nosocomial Infections Surveillance Systems Hospitals. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modelling. Infect Control Hosp Epidemiol 1998; 19: 388-94.
12. Hjaltested EK, Bernatoniene J, Erlendsdottir H, et al. Resistance in respiratory tract pathogens and antimicrobial use in Icelandic and Lithuanian children. Scand J Infect Dis. 35:2003;21-26
13. Kahlmeter G, Menday P, Cars O. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother. 52:2003;1005-1010